Logo
Posted: March 21, 2007

Europe about to triple nanotechnology funding
(Nanowerk News) The EU's largest ever funding programme for research and technological development, the Seventh Framework Programme (FP7), was launched on January 1, 2007. Under the old Sixth Framework Programme (FP6), between 2002 to 2006 more than €1.3 billion (approx $1.7 billion) was spent on more than 550 projects related to nanotechnology R&D.
Seventh Framework Programme
Under FP7, running from 2007 to 2013, funding for nanotechnology related projects is expected to reach €3.5 billion, out of a total budget of €50.5 billion. €300-400 million is expected to be spent already in 2007.
Cordis maintains a comprehensive nanotechnology page on its website with lots of resources regarding nanotechnology related project calls in FP7.
Currently there are over 40 open calls on nanoscience and nanotechnology projects in FP7:
Nanoscience
  • NMP-2007-1.1-1 Nano-scale mechanisms of bio/non-bio interactions
  • NMP-2007-1.1-2 Self-assembling and self-organisation
  • NMP-2007-1.1-3 Support to ICPC researchers in nanotechnology and creation of a free and open electronic archive of nanosciences and nanotechnologies scientific and technical publications
  • NMP-2007-1.1-4 Development of methodology, collection and elaboration of scientific-technical and socio-economic data and studies on nanosciences and nanotechnologies, including risk assessment, and establishment of an observatory
  • NMP-2007-1.1-5 ERANET Plus in nanosciences
    •  Technology Development
  • NMP-2007-1.2-1 Pilot lines to study, develop and up-scale nanotechnology-based processes from laboratory
  • NMP-2007-1.2-2 Equipment and methods for nanotechnology
  • NMP-2007-1.2-3 Analysis of the ethical, regulatory, social and economic environment of nanomedicine
  • NMP-2007-1.2-4 Coordination in nanometrology
  • NMP-2007-1.2-5 Examining capacity building in nanobiotechnology
  • NMP-2007-3.4-1 Rapid Manufacturing Concepts for Small Series Industrial Production
  • NMP-2007-3.5-1 Processes and Equipment for High Quality Industrial Production of 3-Dimensional Nanosurfaces
  • NMP-2007-3.5-2 Production Technologies and equipment for Micro-Manufacturing
  • NMP-2007-4.0-2 Application of new materials including bio-based fibres in high-added value textile products
    •  Impact Assessment and Societal Issues
  • NMP-2007-1.3-1 Specific, easy-to-use portable devices for measurement and analysis
  • NMP-2007-1.3-2 Risk assessment of engineered nanoparticles on health and the environment
  • NMP-2007-1.3-3 Scientific review on the data and studies on the potential impact on health, safety and the environment of engineered nanoparticles
  • NMP-2007-1.3-4 Creation of a critical and commented database on the health, safety and environmental impact of nanoparticles
  • NMP-2007-1.3-5 Coordination in studying the environmental, safety and health impact of engineered nanoparticles and nanotechnology based materials and products
  • HEALTH-2007-1.3-4 Alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics
  • SiS-2007-1.2.3.2-CT Science in Society: Nanoscience and Nanotechnology
    •  Nanomaterials
  • NMP-2007-2.1.1 Nanostructured polymer-matrix composites
  • NMP-2007-2.1.2 Nanostructured coatings and thin films
  • NMP-2007-2.1.3 Characterisation of nanostructured materials
  • NMP-2007-2.2-1 Organic materials for electronics and photonics
  • NMP-2007-2.2-2 Nanostructured materials with tailored magnetic properties
  • NMP-2007-2.2.-3 Advanced material architectures for energy conversion
  • NMP-2007-2.3.-1 Highly porous bioactive scaffolds controlling angiogenesis for tissue engineering
  • NMP-2007-2.4-2 Nanostructured catalysts with tailor-made functional surfaces
  • NMP-2007-2.4-3 Renewable materials for functional packaging applications
  • NMP-2007-2.5-2 Modelling of microstructural evolution under work conditions and in materials processing
    •  Nanomedicine
  • NMP-2007-4.0-4 Substantial innovation in the European medical industry: development of nanotechnology-based systems for in-vivo diagnosis and therapy
  • HEALTH-2007-2.4.1-7 Improving targeted drug delivery to cancer cells for cancer therapeutics other than gene therapy
  • HEALTH-2007-1.2.3 Novel targeted imaging probes for early in vivo diagnosis and/or evaluation of response to therapy
  • ICT-2007-5.1 Personal Health Systems for Monitoring and Point-of-Care diagnostics
    •  Nanoelectronics
  • ICT-2007.3.1 Next generation nanoelectronics components and electronics integration
  • ICT-2007.8.1 Nano-scale ICT devices and systems
    •  Other
  • INFRA-2007-2.2.1.27 PRINS, Pan-European Research Infrastructures for Nanostructures
  • ICT-2007-C FET (Future and Emerging Technologies)
  • ENERGY-2007.1.2.4 Novel nanostructured materials for hydrogen storage
  • KBBE-2007-2-3-04 Nano-devices for quality assurance, food safety and product properties
  • KBBE-2007-2-4-04 Innovative and safe packaging
  • KBBE-2007-2-5-02 Converging technologies and their potential for the food area
    • Source: Cordis, Nanoforum
     
    6d piezo alignement system